943153-84-2

Upstream product

• 58479-61-1 tert-butylchlorodiphenylsilane 
• 74035-91-9 (4S,5S)-5-(iodomethyl)-4-methyldihydrofuran-2(3H)-one 
• 943153-83-1 methyl (3S,4R)-4-hydroxy-3-methyl-8-(tetrahydro-2H-pyran-2-yloxy)oct-6-ynoate 
• 84071-61-4 methyl (3S)-3-[(2S)-oxiran-2-yl]butanoate 

Downstream Products

• 943153-85-3 (5R,6S)-8-(tert-butyldiphenylsiloxy)-5-(methoxymethoxy)-6-methyloct-2-yn-1-ol 
• 943153-82-0 (E,5R,6S)-8-(tert-butyldiphenylsiloxy)-5-(methoxymethoxy)-6-methyloct-2-ene-1-ol 
• 943153-86-4 {(2S,3S)-3-[(2R,3S)-5-(tert-butyldiphenylsiloxy)-2-(methoxymethoxy)-3-methylpentyl]oxiran-2-yl}methanol 
• 943153-87-5 (3R,5R,6S)-8-(tert-butyldiphenylsiloxy)-5-(methoxymethoxy)-6-methyloctane-1,3-diol 
• 943153-88-6 (3S,4R)-1-(tert-butyldiphenylsiloxy)-4-(methoxymethoxy)-5-[(4R)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl]-3-methylpentane 
• 943153-89-7 (3S,4R)-4-(methoxymethoxy)-5-[(4R)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl]-3-methylpentan-1-ol 
• 943153-90-0 C₂₀H₃₀O₅ 
• 320573-70-4 (3S,5R,6S,Z)-14-methoxy-3-(2-((4-methoxybenzyl)oxy)-ethyl)-5-(methoxymethoxy)-6-methyl-3,4,5,6,7,10-hexahydro-1H-benzo[c][1]oxacyclododecin-1-one 
• 398478-58-5 (3S,5R,6S,E)-14-methoxy-3-(2-((4-methoxybenzyl)oxy)-ethyl)-5-(methoxymethoxy)-6-methyl-3,4,5,6,7,10-hexahydro-1H-benzo[c][1]oxacyclododecin-1-one 
• 398478-56-3 (3R,5R,6S)-1-(4-methoxybenzyloxy)-5-(methoxymethoxy)-6-methylnon-8-en-3-ol 
• 398478-57-4 2-methoxy-6-(prop-2-enyl)benzoic acid (1S,3R,4S)-1-[2-(4-methoxybenzyloxy)ethyl]-3-methoxymethoxy-4-methylhept-6-enyl ester 

Relevant academic research and scientific papers

Stereoselective synthesis of the macrocyclic core of (-)-salicylihalamides A and B

Stereoselective synthesis of the macrocyclic core of salicylihalamides A and B is described. The synthetic strategy features stereoselective iodolactonization, Sharpless asymmetric epoxidation, Mitsunobu esterification, and ring-closing metathesis. Georg